Filter Results:
(668)
Show Results For
- All HBS Web
(1,046)
- News (166)
- Research (668)
- Events (1)
- Multimedia (2)
- Faculty Publications (380)
Show Results For
- All HBS Web
(1,046)
- News (166)
- Research (668)
- Events (1)
- Multimedia (2)
- Faculty Publications (380)
Sort by
- winter 1992
- Article
Challenging Conventional Explanations of Cooperation: Negotiation Analysis and the Case of Epistemic Communities
Sebenius, James K. "Challenging Conventional Explanations of Cooperation: Negotiation Analysis and the Case of Epistemic Communities." International Organization 46, no. 1 (winter 1992): 323–365. (Reprinted in:
Knowledge, Power, and International Policy Coordination. Studies in International Relations, 323-366,
edited by Peter M. Haas. Columbia, SC: University of South Carolina Press, 1997.)
Knowledge, Power, and International Policy Coordination. Studies in International Relations, 323-366,
edited by Peter M. Haas. Columbia, SC: University of South Carolina Press, 1997.)
- May 2021
- Supplement
Paul Levy: Confronting a 'Corporate Campaign' (B)
By: James K. Sebenius and Isaac Silberberg
Paul Levy, CEO of the Beth Israel Deaconess Medical Center hospital is faced with a formidable negotiation campaign to unionize staff at BIDMC. Armed only with his personal blog, does Paul stand a chance against the union's multi-million dollar organizing budget? View Details
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details
Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- January 2017
- Supplement
Bayer AG: Bidding to Win Merck's OTC Business
By: Benjamin C. Esty, Marc Baaij and Arjen Mulder
- January 2017
- Case
Bayer AG: Bidding to Win Merck's OTC Business
By: Benjamin C. Esty, Marc Baaij and Arjen Mulder
Shortly after submitting their best and final offer to acquire Merck's Consumer Care Division (a collection of "over-the-counter" (OTC) products with sales totaling $2 billion), the Bayer M&A team was given a chance to revise their bid because another potential... View Details
Keywords: Acquisition; Bidding Strategy; Valuing Synergies; Negotiations; Corporate Strategy; Business Unit Strategy; Bidding Process; Discounted Cash Flow; Cross-border M&A; Tax Shields; Valuation; Competitive Strategy; Auctions; Bids and Bidding; Germany; United States; United Kingdom
Esty, Benjamin C., Marc Baaij, and Arjen Mulder. "Bayer AG: Bidding to Win Merck's OTC Business." Harvard Business School Case 217-021, January 2017.
- June 2014
- Article
Mastering the Intermediaries: Strategies for Dealing with the Likes of Google, Amazon, and Kayak
By: Benjamin Edelman
Many companies depend on powerful platforms which distinctively influence buyers' purchasing. (Consider, Google, Amazon, and myriad others in their respective spheres.) I consider implications of these platforms' market power, then suggest strategies to help companies... View Details
Keywords: Competition; Market Power; Dominance; Advertising Campaigns; Marketing Channels; Agreements and Arrangements; Competitive Strategy; Negotiation; Transportation Industry; Information Technology Industry; Web Services Industry
Edelman, Benjamin. "Mastering the Intermediaries: Strategies for Dealing with the Likes of Google, Amazon, and Kayak." Harvard Business Review 92, no. 6 (June 2014): 86–92.
- 09 Jan 2019
- Research & Ideas
The UK Needs a Bold Strategy Around Competition to Survive Brexit
put in place strategies to drive prosperity in the regions. In addition, its policy has also focused on a few strong industries, such as pharmaceuticals, aerospace, and car manufacturing, while ignoring that the broader economy that has... View Details
Keywords: by Michael Blanding
- January 2014 (Revised October 2014)
- Supplement
Mittal Steel's Pursuit of Arcelor (B)
By: Paul M. Healy and Penelope Rossano
Lakshmi Mittal, CEO of Mittal Steel, a UK-based company with Indian roots, took advantage of a weakened Arcelor that had successfully won a bidding war for Canadian steel company Dofasco, with an unsolicited bid to buy the company. Mittal's plans for acquiring Arcelor... View Details
- Research Summary
Overview
Professor Brooks studies the psychology of conversation and emotion—topics at the intersection of how people think, feel, and interact. From pitching ideas to seeking advice, from asking questions to giving compliments, from talking about (or hiding) our feelings and... View Details
- 2015
- Chapter
The Business Model: Nature and Benefits
By: Ramon Casadesus-Masanell and John Heilbron
This paper considers the nature of the business model and its strategic relevance to negotiations. We elaborate a substantive definition of the business model as decisions enforced by the authority of the firm; this definition enables the analysis of business models... View Details
Keywords: Business Models; Value Capture; Value-Based Business Strategy; Ambivalent Value; Business Model; Value; Negotiation Deal
Casadesus-Masanell, Ramon, and John Heilbron. "The Business Model: Nature and Benefits." Chap. 1 in Business Models and Modelling. Vol. 33, edited by Charles Baden-Fuller and Vincent Mangematin. Advances in Strategic Management. Emerald Group Publishing, 2015.
- 2015
- Working Paper
The Business Model: Nature and Benefits
By: Ramon Casadesus-Masanell and John Heilbron
This paper considers the nature of the business model and its strategic relevance to negotiations. We elaborate a substantive definition of the business model as decisions enforced by the authority of the firm; this definition enables the analysis of business models... View Details
Keywords: Business Models; Value Capture; Value-Based Business Strategy; Ambivalent Value; Business Model; Negotiation Deal
Casadesus-Masanell, Ramon, and John Heilbron. "The Business Model: Nature and Benefits." Harvard Business School Working Paper, No. 15-089, May 2015. (Revised June 2015.)
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details
Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- December 2016
- Article
Through the Mud or in the Boardroom: Examining Activist Types and Their Strategies in Targeting Firms for Social Change
By: Charles Eesley, K. A. DeCelles and Michael Lenox
We examine the variety of activist groups and their tactics in demanding firms’ social change. While extant work does not usually distinguish among activist types or their variety of tactics, we show that different activists (e.g., social movement organizations vs.... View Details
Eesley, Charles, K. A. DeCelles, and Michael Lenox. "Through the Mud or in the Boardroom: Examining Activist Types and Their Strategies in Targeting Firms for Social Change." Strategic Management Journal 37, no. 12 (December 2016): 2425–2440.
- May 2018
- Teaching Note
Mubadala and EBX: To X or to X It?
By: Nori Gerardo Lietz and Sayiddah Fatima McCree
On April 3, 2013, Hani Barhoush and Oscar Fahlgren of Mubadala Capital (“Mubadala”) considered how to salvage Mubadala’s $2 billion preferred equity investment of a 5.63% stake in the EBX Group. At the time, EBX was the holding company of a myriad of subsidiaries and... View Details
- January 2014 (Revised March 2015)
- Technical Note
The Market Power of Platform-Mediated Networks
By: Benjamin Edelman
This note provides criteria to evaluate the power of a platform-mediated network. For a company considering building such a network or an investor considering funding such an effort, this analysis reveals the scope and desirability of the opportunity. Meanwhile, for a... View Details
Keywords: Intermediaries; Platforms; Platform Strategy; Business Model; Agreements and Arrangements; Distribution Channels; Networks; Technology Platform; Telecommunications Industry; Travel Industry; Financial Services Industry
Edelman, Benjamin. "The Market Power of Platform-Mediated Networks." Harvard Business School Technical Note 914-029, January 2014. (Revised March 2015.) (request a courtesy copy.)
- October 2014 (Revised October 2015)
- Case
Procter & Gamble, 2015
By: John R. Wells and Galen Danskin
On July 30, 2015, Procter & Gamble (P&G) announced headline double-digit earnings per share growth for the year ended June 30. A closer look at the numbers suggested a less healthy picture. Sales, volumes, and operating profits were down. Investors were not impressed;... View Details
Keywords: Strategic Analysis; Strategy; Consumer Products; Global; Procter & Gamble; Corporate Strategy; Competition; Consumer Products Industry
Wells, John R., and Galen Danskin. "Procter & Gamble, 2015." Harvard Business School Case 715-429, October 2014. (Revised October 2015.)
- March 2014
- Case
Novartis' Sandoz: Between Generics and Pharma
By: Krishna Palepu and Carin-Isabel Knoop
Sandoz, which made a significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar portfolio. What... View Details
Keywords: Global Strategy And Leadership; Managing Within A Multi-Business Organization; Generic Pharmaceuticals; Global Strategy
Palepu, Krishna, and Carin-Isabel Knoop. "Novartis' Sandoz: Between Generics and Pharma." Harvard Business School Case 114-033, March 2014.
- December 2005 (Revised October 2013)
- Case
Fred Khosravi and AccessClosure (A)
By: Richard Hamermesh and Liz Kind
Fred Khosravi is a serial medical device entrepreneur. In his latest venture, he must decide whether to sell now or continue to develop his current product and whether to market it, sell the company, or IPO. View Details
Keywords: Negotiation; Medical Devices; Venture Capital; Life Sciences; Health Care Industry; Healthcare Technology; Healthcare Ventures; Business Startups; Decision Choices and Conditions; Entrepreneurship; Growth and Development Strategy; Medical Devices and Supplies Industry; United States
Hamermesh, Richard, and Liz Kind. "Fred Khosravi and AccessClosure (A)." Harvard Business School Case 806-044, December 2005. (Revised October 2013.)
- March–April 2024
- Article
Case Study: Navigating Labor Unrest
By: Jorge Tamayo
Paulo Ferreira, the president of Luna Brazil, has an ambitious plan to turn around the dismal performance of the plant he oversees in Campinas. The wrinkle is, he needs the buy-in of the powerful local union, which is still smarting from a 10-year-old labor conflict... View Details
Keywords: Strategy And Execution; Layoffs; Manufacturing; Labor and Management Relations; Labor Unions; Negotiation Tactics; Conflict and Resolution; Performance Improvement; Corporate Strategy; Manufacturing Industry; Brazil
Tamayo, Jorge. "Case Study: Navigating Labor Unrest." Harvard Business Review 102, no. 2 (March–April 2024): 144–149.
- May 2022
- Case
The NFL’s $110-Billion Media Rights Deals
By: Anita Elberse and Elizabeth Warner
On March 18, 2021, Brian Rolapp, chief media and business officer at the National Football League (NFL) presented the results of a months-long effort to renegotiate rights deals with the NFL’s current partners in television—the media conglomerates behind the networks... View Details
Keywords: Sports; Entertainment; Media; Marketing; Strategy; General Management; Negotiation; Partners and Partnerships; Competition; Media and Broadcasting Industry; Sports Industry
Elberse, Anita, and Elizabeth Warner. "The NFL’s $110-Billion Media Rights Deals." Harvard Business School Case 522-090, May 2022.